Dengue-associated myositis exhibited a benign clinical course in this symptomatic pediatric cohort. However, these findings suggest that clinical and laboratory parameters may support a risk-based clinical approach to patient monitoring and management; prospective studies are needed to validate risk stratification strategies.
Birne et al. (Sat,) studied this question.